000 | 01769 a2200493 4500 | ||
---|---|---|---|
005 | 20250516102951.0 | ||
264 | 0 | _c20130321 | |
008 | 201303s 0 0 eng d | ||
022 | _a1932-6203 | ||
024 | 7 |
_a10.1371/journal.pone.0040860 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRöder, Ira Verena | |
245 | 0 | 0 |
_aParticipation of myosin Va and Pka type I in the regeneration of neuromuscular junctions. _h[electronic resource] |
260 |
_bPloS one _c2012 |
||
300 |
_ae40860 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcitonin Gene-Related Peptide _xmetabolism |
650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
650 | 0 | 4 |
_aCyclic AMP-Dependent Protein Kinase Type I _xmetabolism |
650 | 0 | 4 |
_aElapid Venoms _xpharmacology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Inbred mdx |
650 | 0 | 4 |
_aMuscle, Skeletal _xdrug effects |
650 | 0 | 4 |
_aMuscular Dystrophy, Animal _xpathology |
650 | 0 | 4 |
_aMyosin Heavy Chains _xmetabolism |
650 | 0 | 4 |
_aMyosin Type V _xmetabolism |
650 | 0 | 4 |
_aNeuromuscular Junction _xdrug effects |
650 | 0 | 4 |
_aProtein Stability _xdrug effects |
650 | 0 | 4 |
_aReceptors, Cholinergic _xmetabolism |
650 | 0 | 4 |
_aRegeneration _xdrug effects |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aSynapses _xdrug effects |
700 | 1 | _aStrack, Siegfried | |
700 | 1 | _aReischl, Markus | |
700 | 1 | _aDahley, Oliver | |
700 | 1 | _aKhan, Muzamil Majid | |
700 | 1 | _aKassel, Olivier | |
700 | 1 | _aZaccolo, Manuela | |
700 | 1 | _aRudolf, Rüdiger | |
773 | 0 |
_tPloS one _gvol. 7 _gno. 7 _gp. e40860 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0040860 _zAvailable from publisher's website |
999 |
_c21961234 _d21961234 |